Page 4 - Kieron Harbinson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kieron harbinson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kieron Harbinson Today - Breaking & Trending Today

Omega signs first customer for its new Covid-19 laboratory testing service

Omega signs first customer for its new Covid-19 laboratory testing service
heraldscotland.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from heraldscotland.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Kieron Harbinson , Omega Diagnostics , ஒன்றுபட்டது கிஂக்டம் , ஒமேகா பரிசோதனை ,

Investegate |Omega Diagnostics Gp Announcements | Omega Diagnostics Gp: Director/PDMR Shareholding

Investegate announcements from Omega Diagnostics Gp, Director/PDMR Shareholding ....

City Of , United Kingdom , Paul Mcmanus , Colin King , Kieron Harbinson , Geoff Nash Teddy Whiley , Lianne Cawthorne , William Rhodes , Company Ordinary , London Stock Exchange , Omega Diagnostics Group Plc , Cap Ltd , Company Third Unapproved Scheme , Omega Diagnostics Group , Total Voting , Third Unapproved Scheme , Non Executive Director , Ordinary Shares , Market Abuse Regulation , Chief Executive , Group Finance , Teddy Whiley , Corporate Finance , Share Options , Investegate Announcements , Investegate Company Announcements ,

Investegate |Omega Diagnostics Gp Announcements | Omega Diagnostics Gp: AbC-19TM rapid antibody test performance data

A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
1. Obtains access to the information in a personal capacity;
2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so; ....

City Of , United Kingdom , Paul Mcmanus , Colin King , Kieron Harbinson , Geoff Nash Edward Whiley , Lianne Cawthorne , Chris Molloy , Cap Ltd , Public Health England , Omega Diagnostics Group , United Kingdom Rapid Test Consortium , Chief Executive , Group Finance , Edward Whiley , Corporate Finance , Investegate Announcements , Investegate Company Announcements , Omega Diagnostics Gp , Regulatory News Service , Regulatory News Service And , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் , பால் மக்ம்யாநஸ் , கொலின் கிங் , ஜியோஃப் நஷ் எட்வர்ட் அதே நேரத்தில் ,

Investegate |Omega Diagnostics Gp Announcements | Omega Diagnostics Gp: UK Government contract and trading update

Investegate announcements from Omega Diagnostics Gp, UK Government contract and trading update ....

United Kingdom , Paul Mcmanus , Simon Douglas , Colin King , Kieron Harbinson , Geoff Nash Teddy Whiley , Lianne Cawthorne , Company Food Intolerance , Clinton Health Access Initiative Inc , Cap Ltd , Department Of Health , Omega Diagnostics Group , Kingdom Government , Social Care , United Kingdom Government , Life Science , Non Executive Chairman , Food Intolerance , Clinton Health Access Initiative , Chief Executive Officer , Chief Executive , Group Finance , Teddy Whiley , Corporate Finance , Investegate Announcements , Investegate Company Announcements ,

Investegate |Omega Diagnostics Gp Announcements | Omega Diagnostics Gp: Directorate Change

Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance testing, announces the appointment of Dr Simon Douglas as independent Non-Executive Chairman. Simon has been appointed to the Board with immediate effect, after a thorough search process that was conducted with the help of Snedden Campbell Ltd. Simon has also become a member of both the Audit Committee and the Remuneration Committee.

Simon has 25 years of Board level experience at both early stage and public businesses within the Diagnostics, Life Science and BioPharma industries. Simon is currently Non-Executive Chairman at AIM listed Fusion Antibodies plc, having previously served as its Chief Executive Officer up until 2011. Simon is also Non-Executive Chairman of C-Major Medical, a private limited company. Simon holds a PhD in in-vivo Diagnostics and an MPhil in Immunology, both from the University of Southampton. ....

Paul Mcmanus , Simon Douglas , Colin King , Simon Gordon Douglas , Kieron Harbinson , Geoff Nash Teddy Whiley , Lianne Cawthorne , University Of Southampton , Biofortuna Ltd , Cap Ltd , Snedden Campbell Ltd , Omega Diagnostics Group , Remuneration Committee , Audit Committee , Snedden Campbell , Life Science , Non Executive Chairman , Fusion Antibodies , Chief Executive Officer , C Major Medical , Bill Rhodes , Interim Non Executive Chairman , Non Executive Director , Interim Chairman , Food Intolerance , Schedule Two ,